Xeraya Capital, the venturing arm of Malaysia’s sovereign wealth fund Khazanah Nasional Berhad, has led a $60m fundraising round for healthtech firm Rapid Micro Biosystems, Deal Street Asia has reported.

The round was co-led by the Bain Capital Life Sciences Fund and also featured Asahi Kasei Medical, Longitude Capital, Quaker Partners, TVM Capital, and Richard K. Mellon and Sons.